Back to Search Start Over

Engineered EVs for Oxidative Stress Protection.

Authors :
Tolomeo, Anna Maria
Quarta, Santina
Biasiolo, Alessandra
Ruvoletto, Mariagrazia
Pozzobon, Michela
De Lazzari, Giada
Malvicini, Ricardo
Turato, Cristian
Arrigoni, Giorgio
Pontisso, Patrizia
Muraca, Maurizio
Source :
Pharmaceuticals (14248247); Aug2021, Vol. 14 Issue 8, p703, 1p
Publication Year :
2021

Abstract

Extracellular vesicles (EVs) are increasingly studied as vectors for drug delivery because they can transfer a variety of molecules across biological barriers. SerpinB3 is a serine protease inhibitor that has shown a protective anti-apoptotic function in a variety of stressful conditions. The aim of this study was to evaluate protection from oxidative stress-induced damage, using extracellular vesicles that overexpress SerpinB3 (EVs-SB3) in order to enhance the effect of extracellular vesicles on cellular homeostasis. EVs-SB3s were obtained from HepG2 cells engineered to overexpress SerpinB3 and they revealed significant proteomic changes, mostly characterized by a reduced expression of other proteins compared with EVs from non-engineered cells. These EV preparations showed a significantly higher protection from H<subscript>2</subscript>O<subscript>2</subscript> induced oxidative stress in both the hepatoma cell line and in primary cardiomyocytes, compared to cells treated with naïve EVs or SerpinB3 alone, used at the same concentration. In conclusion, the induction of SerpinB3 transgene expression results in the secretion of EVs enriched with the protein product that exhibits enhanced cytoprotective activity, compared with naïve EVs or the nude SerpinB3 protein. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
14248247
Volume :
14
Issue :
8
Database :
Complementary Index
Journal :
Pharmaceuticals (14248247)
Publication Type :
Academic Journal
Accession number :
152127987
Full Text :
https://doi.org/10.3390/ph14080703